{"CreationDate":"\/Date(1416504371193)\/","AverageQuestionsPerDay":0,"AverageAnswersPerDay":0,"AveragePostsPerDay":0,"Views":0,"UpVotes":0,"DownVotes":0,"AccountId":1947029,"LastAccessDate":"\/Date(1453221338123)\/","Reputation":101,"PostStats":{"PostsMade":0,"TotalViews":0,"Questions":0,"TotalWordsForQuestions":0,"TotalWordsForAnswers":0,"TotalTitleWordCount":0,"HighestScoredQuestion":0,"LowestScoredQuestion":0,"TotalCommentsOnQuestions":0,"Answers":0,"HighestScoredAnswer":0,"LowestScoredAnswer":0,"TotalCommentsOnPosts":0,"TotalCommentsOnAnswers":0,"TotalAcceptedAnswers":0,"AverageWordsPerAnswer":0,"AverageViewsPerPost":0,"AverageAcceptedAnswers":0,"LongestQuestionWordCount":0,"ShortestQuestionWordCount":0,"LongestAnswerWordCount":0,"ShortestAnswerWordCount":0,"LongestQuestionTitleWordCount":0,"AverageQuestionTitleWordCount":0,"AverageWordsPerQuestion":0,"QuestionIds":[],"AnswerIds":[],"Id":null},"BadgeStats":{"TotalBadges":0,"TotalTagBadges":0,"Badges":[],"Id":null,"MostEarnedBadge":null},"CommentStats":{"Comments":0,"LongestCommentWordCount":0,"ShortestCommentWordCount":0,"AverageCommentWordCount":0,"AverageCommentScore":0,"TotalCommentWordCount":0,"HighestScoredComment":0,"LowestScoredComment":0,"CommentScores":[],"Id":null},"Name":"Stefan Gruenwald","Id":"academia.stackexchange.com-1947029","AboutMe":"<p>Founder of Corporate Governance Partners (<a href=\"http://www.cgfunding.com\" rel=\"nofollow\">http://www.cgfunding.com</a>), co-founder, seed investor and Chief Technology Officer of Diagnomics (<a href=\"http://www.diagnomics.com\" rel=\"nofollow\">http://www.diagnomics.com</a>), and Managing Director at <strong>Genautica</strong> (<a href=\"http://www.genautica.com\" rel=\"nofollow\">http://www.genautica.com</a>), co-founder and Head of SAB at DNA SEQ Alliance (<a href=\"http://www.dna-seqalliance.com\" rel=\"nofollow\">http://www.dna-seqalliance.com</a>) with over 25 years experience in the Biotech Industry in San Diego, CA. Was the VP or R&amp;D at PharMingen (91-97) and the VP R&amp;D at Becton Dickinson (97-00). Founder of Orbigen (00-04). Involved in several merger / acquisitions in the $200+ MM range.</p>\n\n<p>Academic degree: MD / PhD (<strong>summa cum laude, Best-Thesis-Of-The-Year Award</strong>). Involved in technology scouting and evaluation for over 15 years.</p>\n\n<p>Initiator and curator of popular <b>Science Newsletter</b> (<a href=\"http://www.scoop.it/t/amazing-science\" rel=\"nofollow\">http://www.scoop.it/t/amazing-science</a>) with over <em>275,000 reads</em>. Fluent in English and German. Studied Human Medicine, Biology and Physics at the Johann-Wolfgang-Goethe University in Frankfurt / Germany. Broad scientific knowledge in many disciplines, including Biotechnology and Nanotechnology.</p>\n\n<p>Specialties: Biotechnology management, start-up company management, Fortune 100 company management, mergers and aquisitions, Venture Capital, Private Equity, Funds of Funds, International contacts, Russia, China. Nanotechnology Investment. Computer skills: Assembly language, HTML5, CSS3, Javascript, jQuery, PHP, MySQL, UNIX and python.</p>\n\n<p>You can email me (sgruenwald at cgfunding.com) and find me on LinkedIn (sgruenwald), Twitter (@sgruenwald), Pinterest (genautica), Rebelmouse (sgruenwald) and SKYPE (esmestefan).</p>\n","Location":"San Diego, CA"}
